2 citations
,
March 2009 in “Journal of Clinical Dermatology” This study found that topical 5% minoxidil solution is effective and well tolerated for promoting hair growth in Korean men with androgenetic alopecia over 24 weeks.
January 2026 in “New Journal of Chemistry” This study synthesized calcium citrate nanoparticles to improve the solubility and reduce the irritation of minoxidil solutions for treating androgenetic alopecia.
5 citations
,
January 2018 in “Italian journal of dermatology and venereology” This study discusses that while the precise mechanism of minoxidil is not fully understood, its efficacy in stimulating hair growth and treating androgenetic alopecia is well-supported, with evidence showing it increases hair count and hair follicle size in treated patients.
August 2025 in “Journal of Cosmetic Dermatology” This study found that a novel dietary supplement, AGA-P, when combined with minoxidil and finasteride, significantly improved the clinical efficacy of these drugs for treating mild-to-severe androgenic alopecia compared to drug treatment alone over six months.
August 2019 in “Reactions Weekly” Oral minoxidil for hair loss caused mild side effects in some men, but most continued treatment.
May 2025 in “Actas Dermo-Sifiliográficas” This study evaluated high-dose oral minoxidil treatment in 57 patients with androgenetic alopecia and found it improved hair density by 10-30% in most cases, but 24.6% experienced adverse effects like hypertrichosis and tachycardia, indicating further research is needed to optimize safety and efficacy.
3 citations
,
January 1988 Minoxidil helps hair grow, especially in people with mild hair loss.
38 citations
,
January 1993 in “PubMed” This article discusses the impact of minoxidil on legitimizing scientific research in common baldness and reports no new clinical findings.
January 2006 in “Chinese Journal of Aesthetic Medicine” In this study, lipo-minoxidil was found to increase vascular endothelial growth factor expression in the skin of C57BL/6 mice more than standard minoxidil formulations.
This study found that the novel alcohol-free topical foam CG2001, combining minoxidil and finasteride, was safe and well-tolerated in Chinese males with androgenetic alopecia, with significantly lower systemic exposure to finasteride compared to oral administration, potentially reducing sexual side effects.
July 2026 in “Mendeley Data” Higher doses of oral minoxidil can help hair growth but need careful monitoring for side effects.
5 citations
,
April 2021 in “Frontiers in Pharmacology” In this mouse study, the combination of minoxidil-coated lysozyme microbubbles and ultrasound significantly enhanced hair growth compared to minoxidil alone.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” PRP may be more effective and satisfying for hair regrowth than minoxidil, with similar safety.
September 1989 in “Drug and Therapeutics Bulletin” This article discusses the use of oral and topical minoxidil for hair growth, detailing its effects and the regulatory status of topical minoxidil in the UK, but it presents no new clinical results.
July 2021 in “Indian journal of drugs in dermatology” In this study, the combination of intradermal meso-solution and topical 5% minoxidil significantly increased hair re-growth in men with androgenetic alopecia compared to minoxidil alone.
14 citations
,
April 1987 in “PubMed” In an open trial, 2.8% minoxidil solution applied topically stimulated new hair growth in 45% of male patients with male pattern alopecia, though patient self-assessments were more favorable than objective evaluations.
July 2026 in “Mendeley Data” Higher doses of oral minoxidil can help hair growth but may cause side effects.
July 2026 in “Mendeley Data” Higher doses of oral minoxidil can help hair growth but may cause side effects.
February 2026 in “Drug Delivery and Translational Research” Chitosan-coated nanocapsules improve minoxidil delivery for better hair regrowth.
February 2025 in “Journal of Dermatological Treatment” The study explores the potential effectiveness of low-dose oral minoxidil in treating short anagen hair syndrome, suggesting it may be a viable treatment option despite the condition often resolving spontaneously with puberty.
44 citations
,
March 1987 in “Journal of The American Academy of Dermatology” This study found that both 2% and 3% topical minoxidil were more effective than placebo in promoting hair growth for men with male pattern baldness over 12 months.
Low-dose oral minoxidil is effective and generally safe for treating hair loss in women.
May 2013 in “DOAJ (DOAJ: Directory of Open Access Journals)” This study found that a multimodal microemulsion containing minoxidil, diclofenac, and tea tree oil was significantly more effective and stable than minoxidil alone in treating androgenic alopecia over a 32-week period.
This study concluded that 5% minoxidil foam or solution applied twice daily is effective and safe for treating male androgenetic alopecia.
7 citations
,
December 2021 in “Pharmaceutics” This study developed a nanoemulsion of garlic oil and apple cider vinegar loaded with minoxidil to enhance drug permeation through skin, reporting improved ex vivo skin permeation parameters compared to an aqueous dispersion of minoxidil, suggesting potential benefits for treating alopecia areata.
1 citations
,
September 2021 in “Frontiers in Endocrinology” This case report describes the use of topical minoxidil to successfully promote facial hair growth in a 17-year-old trans male unable to start testosterone therapy, with skin dryness as the only reported side effect.
April 2022 in “Journal of Cosmetic Dermatology” In this study, 98 days of using Trimax-360 Serum, a botanical-based treatment, significantly improved hair density, thickness, and growth rate in adults with mild to moderate alopecia, with no adverse effects reported.
March 2021 in “Berkala Ilmu Kesehatan Kulit dan Kelamin” This review discusses the treatment options for male androgenetic alopecia, including FDA-approved therapies and new possibilities, but reports no new clinical results.
25 citations
,
January 2002 in “Folia Pharmacologica Japonica” This article reviews the proposed mechanism of minoxidil in treating androgenetic alopecia, suggesting it may prolong the anagen phase by modulating cell growth factors and vascular activity, but reports no new results.
5 citations
,
January 2020 in “Skin Research and Technology” This study reported that combined oral finasteride and topical 5% minoxidil treatment in men with male-pattern hair loss improved hair growth by initiating anagen in pre-existing but deficient follicles, yet the growth rates remained unchanged and did not normalize hair productivity.